ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Allegheny Wins NSABP Recompetition; Luri Cancer Center Hosts Princess Diana

June 14, 1996

Barret’s Less of a Risk Factor For Cancer of the Esophagus

June 24, 2011

Hughes institute Considers More Support For Genome Mapping

August 1, 1986

Exercise May Help Combat Leukemia Patients’ Fatigue

August 28, 2009

Stereotactic Body Radiotherapy Could Improve Overall Survival

July 29, 2011

Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say

May 14, 2010